HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of the carrier state in pigeons infected with Salmonella enterica subspecies enterica serovar typhimurium PT99 by treatment with florfenicol: a matter of pharmacokinetics.

Abstract
Paratyphoid caused by Salmonella enterica subsp. enterica serovar Typhimurium is the main bacterial disease in pigeons. The ability of Salmonella serovar Typhimurium to persist intracellularly inside pigeon macrophages results in the development of chronic carriers, which maintain the infection in the flock. In this study, the effect of drinking-water medication with florfenicol on Salmonella infection in pigeons was examined. The pharmacokinetics of florfenicol in pigeons revealed a relatively high volume of distribution of 2.02 liters/kg of body weight and maximum concentrations in plasma higher than the MICs for the Salmonella strain used (4 microg/ml) but quick clearance of florfenicol due to a short half-life of 1.73 h. Together with highly variable bioavailability and erratic drinking-water uptake, these parameters resulted in the inability to reach a steady-state concentration through the continuous administration of florfenicol in the drinking water. Florfenicol was capable of reducing only moderately the number of intracellular salmonellae in infected pigeon macrophages in vitro. Only at high extracellular concentrations (>16 microg/ml) was a more-than-10-fold reduction of the number of intracellular bacteria noticed. Florfenicol treatment of pigeons via the drinking water from 2 days after experimental inoculation with Salmonella serovar Typhimurium until euthanasia at 16 days postinoculation resulted in a reduction of Salmonella shedding and an improvement in the fecal consistency. However, internal organs in florfenicol-treated pigeons were significantly more heavily colonized than those in untreated pigeons. In conclusion, the oral application of florfenicol for the treatment of pigeon paratyphoid contributes to the development of carrier animals through sub-MIC concentrations in plasma that do not inhibit intracellular persistency.
AuthorsFrank Pasmans, Kris Baert, An Martel, Alain Bousquet-Melou, Ruben Lanckriet, Sandra De Boever, Filip Van Immerseel, Venessa Eeckhaut, Patrick de Backer, Freddy Haesebrouck
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 52 Issue 3 Pg. 954-61 (Mar 2008) ISSN: 0066-4804 [Print] United States
PMID18180355 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • florfenicol
  • Thiamphenicol
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage, pharmacokinetics, pharmacology, therapeutic use)
  • Carrier State (drug therapy, microbiology)
  • Columbidae (microbiology)
  • Feces (microbiology)
  • Macrophages (microbiology)
  • Microbial Sensitivity Tests (statistics & numerical data)
  • Salmonella Infections, Animal (drug therapy, microbiology)
  • Salmonella typhimurium (drug effects, isolation & purification, pathogenicity)
  • Thiamphenicol (administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: